Literature DB >> 3182127

[*primary osteonecrosis of the medial femoral condyle. Unicompartmental or total replacement?].

P Cartier1, G Gaggiotti, J L Jully.   

Abstract

We have inserted 18 Mod II unicondylar knee replacements for idiopathic necrosis of the medial femoral condyle. The age of the patients at operation averaged 72 years, with a range of 49 to 90. The average length of follow up at review was 4 years 6 months, with a range of 2 to 8 years. The only notable complication was deterioration of the lateral compartment if operation had produced overcorrection of the tibiofemoral angle. The stability, level of pain, range of movement and function was satisfactory in 95% of the knees. The average flexion obtained was 115 degrees, and was deliberately restricted to this level to diminish stress on the lateral side. It did not result in aseptic loosening. Most knee flexion deformities were corrected at operation. Laxity and instability before operation were usually due to bone loss rather than ligament insufficiency, and were corrected by the prosthesis. A varus deformity of more than 10 degrees, a flexion deformity greater than 15 degrees or femorotibial subluxation were not considered to be contraindications to this operation.

Entities:  

Mesh:

Year:  1988        PMID: 3182127     DOI: 10.1007/bf00547168

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  19 in total

1.  Osteoarthrosis of the knee. A radiographic investigation.

Authors:  S Ahlbäck
Journal:  Acta Radiol Diagn (Stockh)       Date:  1968

2.  [Radiological measurement of the angular deviation of the knee in the frontal plane].

Authors:  J Duparc; C Massare
Journal:  Ann Radiol (Paris)       Date:  1967

3.  Osteonecrosis of the knee.

Authors:  G C Bauer
Journal:  Clin Orthop Relat Res       Date:  1978 Jan-Feb       Impact factor: 4.176

4.  Spontaneous osteonecrosis of the knee.

Authors:  P M Rozing; J Insall; W H Bohne
Journal:  J Bone Joint Surg Am       Date:  1980-01       Impact factor: 5.284

5.  A five to seven-year follow-up of unicondylar arthroplasty.

Authors:  J Insall; P Aglietti
Journal:  J Bone Joint Surg Am       Date:  1980-12       Impact factor: 5.284

6.  Osteonecrosis of the knee. A clinicopathological study in twenty-eight patients.

Authors:  S C Ahuja; P G Bullough
Journal:  J Bone Joint Surg Am       Date:  1978-03       Impact factor: 5.284

7.  The treatment of osteonecrosis of the medial femoral condyle.

Authors:  P A Lotke; J A Abend; M L Ecker
Journal:  Clin Orthop Relat Res       Date:  1982 Nov-Dec       Impact factor: 4.176

8.  Marmor modular knee in unicompartmental disease. Minimum four-year follow-up.

Authors:  L Marmor
Journal:  J Bone Joint Surg Am       Date:  1979-04       Impact factor: 5.284

9.  [Osteochondritis dissecans and osteonecrosis of the lower end of the femur. Value of bone marrow functional exploration].

Authors:  P Ficat; J Arlet; B Mazières
Journal:  Sem Hop       Date:  1975-06-14

10.  The treatment of spontaneous osteonecrosis of the knee by high tibial osteotomy with and without bone-grafting or drilling of the lesion.

Authors:  T Koshino
Journal:  J Bone Joint Surg Am       Date:  1982-01       Impact factor: 5.284

View more
  3 in total

1.  Is unicompartmental arthroplasty an acceptable option for spontaneous osteonecrosis of the knee?

Authors:  Danilo Bruni; Francesco Iacono; Giovanni Raspugli; Stefano Zaffagnini; Maurilio Marcacci
Journal:  Clin Orthop Relat Res       Date:  2012-01-26       Impact factor: 4.176

2.  Knee arthroplasty for spontaneous osteonecrosis of the knee: unicompartimental vs bicompartimental knee arthroplasty.

Authors:  S Radke; N Wollmerstedt; A Bischoff; J Eulert
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2004-09-24       Impact factor: 4.342

3.  Medial unicompartimental knee arthroplasty for osteonecrosis or osteoarthritis.

Authors:  E Servien; P C M Verdonk; S Lustig; J L Paillot; A D Kara; P Neyret
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-09-10       Impact factor: 4.342

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.